2️⃣ 2nd patient randomised on the MK2870-012 trial! 🎉 Grateful for our dedicated team and courageous patients in contributing to advancing new treatment options ✨@conlethmurphy
💡trial details: https://t.co/bvE0xrRQg9
1️⃣ First patient randomized in the MK2870-010 trial offering Sacituzumab Tirumotecan alone or in combination with Pembrolizumab vs. Standard treatment for unresectable locally advanced/MBC! 🎉
👏 Huge thanks to our team & brave patients for reaching this milestone
Excited to share the news that our cancer centre has been officially certified by ASCO 🎉 Patient-centred care is our focus, and we’re proud to meet expert-backed oncology medical home standards. A great start to #WorldCancerDay 🌎🎗️. Thank you @ASCO@IrishCancerSoc
Frustrating to see discussion (and/or tacit endorsement) of treatments unsupported by evidence at #ASCO24 . At the endometrial cancer session 40% of the audience voted to give trastuzumab deruxtecan to a patient with HER2 2+ IHC. This should be called out more strongly!
Busy day for the Oncology Clinical Trials team, delighted to treat our first patient on the MK3475-C93 trial today, investigating Pembrolizumab vs. Platinum doublet chemotherapy in dMMR Advanced or Recurrent Endometrial Cancer #endometrialcancer#clinicaltrial#cancer#research
We were delighted to talk to Fulbright scholar Conor Hammersley about his research on #masculinity in modern Ireland. In Part 1 he describes the historical & cultural backdrop underpinning masculine identity in Ireland. Listen here: https://t.co/0mef2MVHLC #MensHealth#Fulbright
Hello friends! We have a super episode to open Season 3. We talk to Richard Hogan, pyschotherapist, columnist and author of Parenting the Screenager. He tells us all about the challenges of parenting, how to navigate those tricky teenage years & develop skills to manage adversity
@EibhlinMulroe@cancertrials_ie@AdrianmurphyMD Loving the meeting sessions at #ASCOGU23 but the interaction & bonding with colleagues from medical oncology units in Ireland & abroad & allies such as @cancertrials_ie is such an important part too. Feeling so positive about the future of GU oncology as you can tell from the pic
Here are the details of the public afternoon session, all welcome whether you have cancer or know someone affected by it, are interested in clinical trials or want to check out the art workshops.
Really looking forward to this event organised by @UCCCancerTrials this coming Friday. The afternoon session is free to the public. Get to know the Cancer Research team and take part in some fun workshops. Can’t wait! Register at https://t.co/Tc8dSLE4xU.